Lipase Elevation in Patients with COVID-19

Julia McNabb-Baltar, David X. Jin, Amit S. Grover, Walker D. Redd, Joyce C. Zhou, Kelly E. Hathorn, Thomas R. McCarty, Ahmad N. Bazarbashi, Lin Shen, Walter W. Chan

Research output: Contribution to journalArticlepeer-review

77 Scopus citations


Although coronavirus disease (COVID-19) has been associated with gastrointestinal manifestations, its effect on the pancreas remains unclear. We aimed to assess the frequency and characteristics of hyperlipasemia in patients with COVID-19.METHODS:A retrospective cohort study of hospitalized patients across 6 US centers with COVID-19.RESULTS:Of 71 patients, 9 (12.1%) developed hyperlipasemia, with 2 (2.8%) greater than 3 times upper limit of normal. No patient developed acute pancreatitis. Hyperlipasemia was not associated with poor outcomes or symptoms.DISCUSSION:Although a mild elevation in serum lipase was observed in some patients with COVID-19, clinical acute pancreatitis was not seen.

Original languageEnglish (US)
Pages (from-to)1286-1288
Number of pages3
JournalAmerican Journal of Gastroenterology
Issue number8
StatePublished - Aug 1 2020

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'Lipase Elevation in Patients with COVID-19'. Together they form a unique fingerprint.

Cite this